Related references
Note: Only part of the references are listed.Prolonged higher dose methylprednisolone versus conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS)
Francesco Salton et al.
EUROPEAN RESPIRATORY JOURNAL (2023)
Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia
Mohamed A. Helal et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
A guide to immunotherapy for COVID-19
Frank L. van de Veerdonk et al.
NATURE MEDICINE (2022)
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
Anna L. McNaughton et al.
JCI INSIGHT (2022)
Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19
Yuan-Yuan Yong et al.
CLINICAL IMMUNOLOGY (2022)
Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines
Alessandro Sette et al.
IMMUNOLOGICAL REVIEWS (2022)
The humoral and cellular immune evasion of SARS-CoV-2 Omicron and sub-lineages
Tiandan Xiang et al.
VIROLOGICA SINICA (2022)
Stem cell therapy for COVID-19 pneumonia
Maziar Malekzadeh Kebria et al.
MOLECULAR BIOMEDICINE (2022)
Immunopathology of Hyperinflammation in COVID-19
Joshua N. Gustine et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia et al.
LANCET INFECTIOUS DISEASES (2021)
How should we use convalescent plasma therapies for the management of COVID-19?
Erica M. Wood et al.
BLOOD (2021)
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
Payam Tabarsi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Ni Zhao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
Hadis Fathizadeh et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
Assessing the importance of interleukin-6 in COVID-19
Luke Y. C. Chen et al.
LANCET RESPIRATORY MEDICINE (2021)
Efficacy of canakinumab in mild or severe COVID-19 pneumonia
Falasca Katia et al.
IMMUNITY INFLAMMATION AND DISEASE (2021)
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
Cole J. Batty et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
DNA vaccines against COVID-19: Perspectives and challenges
Marcelle Moura Silveira et al.
LIFE SCIENCES (2021)
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Phillip D. Monk et al.
LANCET RESPIRATORY MEDICINE (2021)
The immune response to SARS-CoV-2 and COVID-19 immunopathology -- Current perspectives
J. L. Boechat et al.
PULMONOLOGY (2021)
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
Dapeng Li et al.
CELL (2021)
Impact of Pneumococcal Urinary Antigen Testing in COVID-19 Patients: Outcomes from the San Matteo COVID-19 Registry (SMACORE)
Pietro Valsecchi et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
The immunology and immunotherapy for COVID-19
Yixin Liu et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2021)
The signal pathways and treatment of cytokine storm in COVID-19
Lan Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy
Federica Melazzini et al.
INTERNAL AND EMERGENCY MEDICINE (2021)
Immunopathogenesis and treatment of cytokine storm in COVID-19
Jae Seok Kim et al.
THERANOSTICS (2021)
COVID-19: what is next for public health?
David L. Heymann et al.
LANCET (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
Michael Letko et al.
NATURE MICROBIOLOGY (2020)
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Huilan Zhang et al.
ANNALS OF INTERNAL MEDICINE (2020)
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Stephen A. Lauer et al.
ANNALS OF INTERNAL MEDICINE (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
Carly G. K. Ziegler et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Annsea Park et al.
CELL HOST & MICROBE (2020)
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
Andrea Padoan et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
Mehmet Soy et al.
CLINICAL RHEUMATOLOGY (2020)
Pulmonary embolism in patients with COVID-19 pneumonia
Florian Bompard et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
Isabella Quinti et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Immunogenicity of a DNA vaccine candidate for COVID-19
Trevor R. F. Smith et al.
NATURE COMMUNICATIONS (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
F. Locatelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover
Annarosa Soresina et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)
On the molecular determinants of the SARS-CoV-2 attack
Darja Kanduc et al.
CLINICAL IMMUNOLOGY (2020)
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia
Sara De Biasi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2020)
Cytokine Storms: Understanding COVID-19
Nilam Mangalmurti et al.
IMMUNITY (2020)
Severe COVID-19: NLRP3 Inflammasome Dysregulated
Daan F. van den Berg et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey L. Freeman et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19
Bhawna Tomar et al.
CELLS (2020)
Comprehensive mapping of immune perturbations associated with severe COVID-19
Leticia Kuri-Cervantes et al.
SCIENCE IMMUNOLOGY (2020)
Early Insights into Immune Responses during COVID-19
Ashley L. St. John et al.
JOURNAL OF IMMUNOLOGY (2020)
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Fabrizio Cantini et al.
JOURNAL OF INFECTION (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression
Samuel B. Polak et al.
MODERN PATHOLOGY (2020)
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J. Mulligan et al.
NATURE (2020)
Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19
F. Javier Ibarrondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew et al.
SCIENCE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology
Flavio Protasio Veras et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
E. J. Anderson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison et al.
TRENDS IN IMMUNOLOGY (2020)
The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies
Elahe Seyed Hosseini et al.
VIROLOGY (2020)
Anakinra treatment in critically ill COVID-19 patients: a prospective cohort study
Emma J. Kooistra et al.
CRITICAL CARE (2020)
Baricitinib restrains the immune dysregulation in patients with severe COVID-19
Vincenzo Bronte et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cell-mediated immunity to SARS-CoV-2
Xiaolin Wang et al.
PEDIATRIC INVESTIGATION (2020)
Associations between blood type and COVID-19 infection, intubation, and death
Michael Zietz et al.
NATURE COMMUNICATIONS (2020)
Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet et al.
LANCET RHEUMATOLOGY (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
The trinity of COVID-19: immunity, inflammation and intervention
Matthew Zirui Tay et al.
NATURE REVIEWS IMMUNOLOGY (2020)
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Robert A Feldman et al.
VACCINE (2019)
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
Kimberly J. Hassett et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Long-term efficacy and safety of mRNA therapy in two murine models of methylmalonic acidemia
Ding An et al.
EBIOMEDICINE (2019)
Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection
Li Liu et al.
JCI INSIGHT (2019)
Novel Platforms for the Development of a Universal influenza vaccine
Arun Kumar et al.
FRONTIERS IN IMMUNOLOGY (2018)
The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
Lan Jiaming et al.
VACCINE (2017)
The impact of the interferon/TNFRelated Apoptosis-inducing Ligand Signaling Axis on Disease Progression in Respiratory viral infection and Beyond
Christin Peteranderl et al.
FRONTIERS IN IMMUNOLOGY (2017)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination
J. A. Otter et al.
JOURNAL OF HOSPITAL INFECTION (2016)
Alveolar Epithelial Cells Are Critical in Protection of the Respiratory Tract by Secretion of Factors Able To Modulate the Activity of Pulmonary Macrophages and Directly Control Bacterial Growth
Olga D. Chuquimia et al.
INFECTION AND IMMUNITY (2013)
A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks et al.
PLOS ONE (2012)
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2011)
Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes
Ana Clara Monsalvo et al.
NATURE MEDICINE (2011)
Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection
HX Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection
WKE Ip et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying eukaryotic cells
SL Fink et al.
INFECTION AND IMMUNITY (2005)
Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
MER Darnell et al.
JOURNAL OF VIROLOGICAL METHODS (2004)
Share Paper
